pharma · Colorectal Cancer Screening · Screening for Colon Cancer · MRKR
ME Therapeutics
Marker Therapeutics
ME Therapeutics is a pharma organization headquartered in Vancouver, CA. It trades on NYSE under ticker MRKR. Primary therapeutic focus areas include Colorectal Cancer Screening, Screening for Colon Cancer, Platinum Sens
Vancouver, British Columbia, CA HQ
2018 Founded
4 Employees
Public company Type
MRKR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Vancouver, British Columbia, CA
- Founded
- 2018
- Employees
- 4
- Programs
- 13
- Drugs
- 10
- Patents
- 27
Mail-in Urine Test for EDCs
Unknown · other · Endocrine Disrupting Chemicals
Mail-in Urine Test for EDCs for Endocrine Disrupting Chemicals is a Unknown program (other) at Marker Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code 1R43ES034312-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Marker Therapeutics
- Phase
- Unknown
- Modality
- other
- Indication
- Endocrine Disrupting Chemicals
- Status
- completed
- Trials
- 1